All Type of News
MSIP supports KRW 317.5 billion into biopharmaceutical fields
The government will support KRW 317.5 billion into the 6 major biotechnology fields, like development of new drugs, to strengthen competitiveness as a country strong in the industry.
In order to secure future potenti...
Rumors about next chairman of KPMA while Former Rep. Hui-Mok Won rises
While there are a lot of advance rumors about who will be the next chairman as Korea Pharmaceutical Manufacturers Association(KPMA) Chairman Kyung-Ho Lee expressed resignation remaining a year left for the end of offi...
OnlinePharm sells ‘PalPal’ too cheap in online market
It was observed not only price of OTC drugs, but have the one of uninsured pharmaceutical drugs including erectile dysfunction treatments been dropping in the online drug market.
Previously, the major cause of the pr...
SK Chemicals’ Vimsk Tab’ became first epilepsy treatment applied for Korean insurance benefitThe SK Chemicals’ epilepsy therapy will be able to secure peerless price competitiveness as registered in Korea for the first time among other same substance products.
SK Chemi...
|
.jpg)
Restriction on KPMA’s office term of chairman and vice chairman to 6 years
The pharmaceutical association’s office term of chairman and vice chairman will be restricted to 6 years at the maximum.
The Korea Pharmaceutical Manufacturers Association(KPMA) held the 3rd Chairmen’s Meeting at She...
KPMA’s board reorganized with owners of pharma
The Kore Pharmaceutical Manufacturers Association’s(KPMA) Chairmen’s Board(Chairman Heng-Myung Lee, Myung In Pharm Chairman) will be formed with owners of pharmaceutical company; thus, it seems decision-making process...
MOHW to decide restriction on Novartis’ insurance benefits within February
Novartis, which has been suspected of providing KRW 2.6 billion rebates, will get a measure of restriction on the health insurance benefit.
The Ministry of Health and Welfare(MOHW) announced the Ministry of Food and ...
Prosecution’s search and seizure on medium pharma right after ‘Lunar New Year’
The prosecution has started to investigate pharmaceutical companies again.
Seoul Southern District Prosecutor’s Office was known to search and seize a medium-sized pharmaceutical company located in Seoul on the 31st....
Which will be first target for prosecution’s rebate investigation this Feb?
Pharmaceutical companies have become tense since the prosecution is taking fine aim at pharmaceutical companies.
According to the pharmaceutical industry, after indicting the multinational pharmaceutical company Nova...
National Health Insurance Service to monitor ‘side effects’ using big data
The National Health Insurance Service(President Sang-Cheol Seong, NHIS) has established a monitoring system to safely use pharmaceutical products using big data, such as the national population, social information, me...
